feed

view company updates

tools

perform investment research

network

join events & discussions

advisory

about us

Redeye Capital

Asarina Pharma: Progress in the menstrual migraine study

Research Note

2019-08-28

10:41

In the initiated phase IIa study in menstrual migraine, the first patient has now been enrolled.

AH

Anders Hedlund

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.